Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jan;65(1):122–126. doi: 10.1128/iai.65.1.122-126.1997

Marked reduction of mouse peritoneal CD5+ B cells by intraperitoneal administration of lipopolysaccharide.

N Paeng 1, N Kido 1, Y Kato 1, T Sugiyama 1, N Koide 1, M Naruse 1, G Z Jiang 1, T Lwin 1, T Yoshida 1, T Yokochi 1
PMCID: PMC174565  PMID: 8975901

Abstract

Intraperitoneal administration of lipopolysaccharide to mice induced a marked reduction of CD5+ B cells in the peritoneal cavity. The reduction was not induced by intravenous, subcutaneous, or oral administration of lipopolysaccharide. The reduction continued for about 10 days after the injection, and the CD5+ B-cell count recovered to the normal state about 14 days after the injection. The reduction of peritoneal CD5+ B cells might be caused by apoptotic cell death. Injection of lipopolysaccharide did not result in production of antibody to lipopolysaccharide. On the other hand, intraperitoneal injection of heat-killed bacteria did not induce a reduction of peritoneal CD5+ B cells and elicited the definite production of antibody to lipopolysaccharide.

Full Text

The Full Text of this article is available as a PDF (180.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Nawata Y. Cytokines mediating the proliferation and differentiation of B-1 lymphocytes and their role in ontogeny and phylogeny. Ann N Y Acad Sci. 1992 May 4;651:200–219. doi: 10.1111/j.1749-6632.1992.tb24616.x. [DOI] [PubMed] [Google Scholar]
  2. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M. A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992;13(8):795–808. doi: 10.1002/cyto.990130802. [DOI] [PubMed] [Google Scholar]
  3. Förster I., Rajewsky K. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol. 1987 Apr;17(4):521–528. doi: 10.1002/eji.1830170414. [DOI] [PubMed] [Google Scholar]
  4. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992 Nov;119(3):493–501. doi: 10.1083/jcb.119.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hardy R. R., Carmack C. E., Li Y. S., Hayakawa K. Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol Rev. 1994 Feb;137:91–118. doi: 10.1111/j.1600-065x.1994.tb00660.x. [DOI] [PubMed] [Google Scholar]
  6. Hayakawa K., Hardy R. R., Herzenberg L. A. Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol. 1986 Apr;16(4):450–456. doi: 10.1002/eji.1830160423. [DOI] [PubMed] [Google Scholar]
  7. Hayakawa K., Hardy R. R. Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage? Annu Rev Immunol. 1988;6:197–218. doi: 10.1146/annurev.iy.06.040188.001213. [DOI] [PubMed] [Google Scholar]
  8. Hayakawa K., Hardy R. R., Parks D. R., Herzenberg L. A. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med. 1983 Jan 1;157(1):202–218. doi: 10.1084/jem.157.1.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Herzenberg L. A., Stall A. M., Lalor P. A., Sidman C., Moore W. A., Parks D. R., Herzenberg L. A. The Ly-1 B cell lineage. Immunol Rev. 1986 Oct;93:81–102. doi: 10.1111/j.1600-065x.1986.tb01503.x. [DOI] [PubMed] [Google Scholar]
  10. Hotz M. A., Gong J., Traganos F., Darzynkiewicz Z. Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry. 1994 Mar 1;15(3):237–244. doi: 10.1002/cyto.990150309. [DOI] [PubMed] [Google Scholar]
  11. Kantor A. B., Herzenberg L. A. Origin of murine B cell lineages. Annu Rev Immunol. 1993;11:501–538. doi: 10.1146/annurev.iy.11.040193.002441. [DOI] [PubMed] [Google Scholar]
  12. Kantor A. B. The development and repertoire of B-1 cells (CD5 B cells). Immunol Today. 1991 Nov;12(11):389–391. doi: 10.1016/0167-5699(91)90136-H. [DOI] [PubMed] [Google Scholar]
  13. Kato N., Kido N., Ohta M., Naito S. Comparative studies on adjuvanticity of Klebsiella O3 lipopolysaccharide and its lipid A and polysaccharide fractions. Immunology. 1985 Feb;54(2):317–324. [PMC free article] [PubMed] [Google Scholar]
  14. Kato Y., Morikawa A., Sugiyama T., Koide N., Jiang G. Z., Takahashi K., Yokochi T. Role of tumor necrosis factor-alpha and glucocorticoid on lipopolysaccharide (LPS)-induced apoptosis of thymocytes. FEMS Immunol Med Microbiol. 1995 Dec;12(3-4):195–204. doi: 10.1111/j.1574-695X.1995.tb00192.x. [DOI] [PubMed] [Google Scholar]
  15. Kearney J. F., McCarthy M. T., Stohrer R., Benjamin W. H., Jr, Briles D. E. Induction of germ-line anti-alpha 1-3 dextran antibody responses in mice by members of the Enterobacteriaceae family. J Immunol. 1985 Nov;135(5):3468–3472. [PubMed] [Google Scholar]
  16. Kroese F. G., Butcher E. C., Stall A. M., Lalor P. A., Adams S., Herzenberg L. A. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol. 1989;1(1):75–84. doi: 10.1093/intimm/1.1.75. [DOI] [PubMed] [Google Scholar]
  17. Marcos M. A., Huetz F., Pereira P., Andreu J. L., Martinez-A C., Coutinho A. Further evidence for coelomic-associated B lymphocytes. Eur J Immunol. 1989 Nov;19(11):2031–2035. doi: 10.1002/eji.1830191110. [DOI] [PubMed] [Google Scholar]
  18. Mercolino T. J., Arnold L. W., Hawkins L. A., Haughton G. Normal mouse peritoneum contains a large population of Ly-1+ (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J Exp Med. 1988 Aug 1;168(2):687–698. doi: 10.1084/jem.168.2.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Murakami M., Honjo T. Involvement of B-1 cells in mucosal immunity and autoimmunity. Immunol Today. 1995 Nov;16(11):534–539. doi: 10.1016/0167-5699(95)80047-6. [DOI] [PubMed] [Google Scholar]
  20. Murakami M., Tsubata T., Okamoto M., Shimizu A., Kumagai S., Imura H., Honjo T. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature. 1992 May 7;357(6373):77–80. doi: 10.1038/357077a0. [DOI] [PubMed] [Google Scholar]
  21. Murakami M., Tsubata T., Shinkura R., Nisitani S., Okamoto M., Yoshioka H., Usui T., Miyawaki S., Honjo T. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med. 1994 Jul 1;180(1):111–121. doi: 10.1084/jem.180.1.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ohta M., Kido N., Hasegawa T., Ito H., Fujii Y., Arakawa Y., Komatsu T., Kato N. Contribution of the mannan O side-chains to the adjuvant action of lipopolysaccharides. Immunology. 1987 Apr;60(4):503–507. [PMC free article] [PubMed] [Google Scholar]
  23. Sidman C. L., Shultz L. D., Hardy R. R., Hayakawa K., Herzenberg L. A. Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. Science. 1986 Jun 13;232(4756):1423–1425. doi: 10.1126/science.3487115. [DOI] [PubMed] [Google Scholar]
  24. Su S. D., Ward M. M., Apicella M. A., Ward R. E. The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-1 lineage. J Immunol. 1991 Jan 1;146(1):327–331. [PubMed] [Google Scholar]
  25. Takahashi K., Fukada M., Kawai M., Yokochi T. Detection of lipopolysaccharide (LPS) and identification of its serotype by an enzyme-linked immunosorbent assay (ELISA) using poly-L-lysine. J Immunol Methods. 1992 Aug 30;153(1-2):67–71. doi: 10.1016/0022-1759(92)90306-e. [DOI] [PubMed] [Google Scholar]
  26. Yokochi T., Inoue Y., Yokoo J., Kimura Y., Kato N. Retention of bacterial lipopolysaccharide at the site of subcutaneous injection. Infect Immun. 1989 Jun;57(6):1786–1791. doi: 10.1128/iai.57.6.1786-1791.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yokochi T., Kato Y., Sugiyama T., Koide N., Morikawa A., Jiang G. Z., Kawai M., Yoshida T., Fukada M., Takahashi K. Lipopolysaccharide induces apoptotic cell death of B memory cells and regulates B cell memory in antigen-nonspecific manner. FEMS Immunol Med Microbiol. 1996 Aug;15(1):1–8. doi: 10.1111/j.1574-695X.1996.tb00351.x. [DOI] [PubMed] [Google Scholar]
  28. Zhang X. M., Morikawa A., Takahashi K., Jiang G. Z., Kato Y., Sugiyama T., Kawai M., Fukada M., Yokochi T. Localization of apoptosis (programmed cell death) in mice by administration of lipopolysaccharide. Microbiol Immunol. 1994;38(8):669–671. doi: 10.1111/j.1348-0421.1994.tb01838.x. [DOI] [PubMed] [Google Scholar]
  29. Zhang Y. H., Takahashi K., Jiang G. Z., Kawai M., Fukada M., Yokochi T. In vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide. Infect Immun. 1993 Dec;61(12):5044–5048. doi: 10.1128/iai.61.12.5044-5048.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van Rooijen N. Are bacterial endotoxins involved in autoimmunity by CD5+ (Ly-1+) B cells? Immunol Today. 1989 Oct;10(10):334–336. doi: 10.1016/0167-5699(89)90189-8. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES